Marketplace Create skill Sign in

GMP Standard Operating Procedure

Drafts inspection-ready GMP standard operating procedures for regulated manufacturing. Covers document control, role accountability, process controls, deviation/CAPA handling, and records management aligned to FDA CGMP (21 CFR 210/211), Part 11, ICH Q7/Q9/Q10, WHO GMP, PIC/S, and EU GMP. Use when creating or overhauling a GMP SOP, preparing for audits or inspections, or building compliance-ready procedures. Trigger: GMP, SOP, CGMP, 21 CFR 210, 21 CFR 211, Part 11, ICH Q7, ICH Q9, ICH Q10, WHO GMP, PIC/S, EU GMP.

ID: ea55d8b3-8daa-43a4-b60c-0d6c370d4fad Version: 0.1.0 License: Apache-2.0 Author: CaseMark Language: en Added: 2026-06-15
⬇ Download

GMP Standard Operating Procedure

Produces a GMP-compliant SOP that is inspection-ready and operationally executable.

Quick Start

  1. Gather inputs: process scope, applicable regulations, QMS context, equipment list, record systems.
  2. Walk through each SOP section below, filling tables and templates.
  3. Mark any unverified citations with [VERIFY].
  4. Route for QA review and approval before release.

Prerequisites

Collect before drafting:

  • Process scope — product type, dosage form, facility class, target markets
  • Applicable regs — FDA CGMP, ICH, WHO, PIC/S, EU GMP, local requirements
  • QMS context — document numbering, approval matrix, related SOPs
  • Equipment — asset IDs, calibration/maintenance/qualification status
  • Record systems — paper vs electronic, Part 11 status
  • Inspection history — FDA 483s, warning letters, open CAPAs
  • SME/approver list — production, QA, QC, engineering, management

SOP Sections

1. Document Control Page

Field Content
SOP Title Precise scope (process/area)
SOP ID Site numbering convention
Version Numeric or semantic
Effective Date Approved use date
Supersedes Prior SOP ID/version
Prepared By Name, role, date
Reviewed By QA, SMEs
Approved By QA/Management
Distribution Controlled locations
Related SOPs IDs and titles
Electronic Signatures Part 11 status

2. Purpose and Scope

Purpose:
This SOP establishes controlled steps for [process] to ensure GMP compliance under [reg citations].

Scope:
Applies to [areas, equipment, product types, personnel]. Excludes [exclusions with rationale].
Interfaces: [related SOP IDs].

3. Regulatory Basis

List only applicable regulations. Use [VERIFY] for unconfirmed citations.

Authority Citation
FDA CGMP 21 CFR Parts 210/211
Electronic records 21 CFR Part 11
ICH Q7 (API), Q9, Q10
WHO TRS GMP guidance
PIC/S GMP Guide
EU EU GMP Guide + Annexes

4. Definitions

Provide GMP-aligned definitions consistent with site QMS. Minimum set: CPP, CQA, deviation, OOS, OOT, batch record, validation, qualification, calibration.

5. Responsibilities Matrix

Role Duties Decisions/Approvals Records Owned
Production Execute SOP steps Stop work for deviations Batch records
QA Approve SOP, review deviations Release/closure authority QA review logs
QC Testing, sampling OOS disposition Lab records
Engineering Maintenance/calibration Equipment readiness PM/calibration logs
Management Resource allocation Final approval Training matrix

6. Materials, Equipment, and Utilities

Item ID/Spec Qualification Calibration/PM Acceptance Criteria
Equipment Asset ID IQ/OQ/PQ status Frequency Tolerance
Materials Grade/spec Supplier status Storage COA required
Utilities Water/HVAC/gases Monitoring Limits Action levels

7. Procedure Steps

Each step must specify role, action, records, and acceptance criteria.

Step Role Action CPP/CQA Hold Point Records
1 Production [imperative action] [range] QA if required [record]
2 QC [sample/test] [spec] QA review [record]
3 QA [verification] N/A Release [record]

Step rules:

  • Include decision points and stop-work criteria
  • Define acceptance ranges for all CPPs/CQAs
  • State required PPE/cleanroom behavior where applicable
  • Require documentation at time of action (concurrent recording)

8. In-Process Controls

Control Frequency Method Acceptance Action if OOR
[Control] [per batch/time] [method] [spec] [action]

9. Deviations, OOS/OOT, and CAPA

  • Document deviation within same shift or defined timeframe
  • Quarantine affected material/lots
  • Initiate root cause investigation
  • Assess impact on product quality and patient safety
  • Implement CAPA with effectiveness checks
  • Document QA disposition and release decision

10. Documentation and Records

Record Owner System Review Timeline Retention
Batch record Production Paper/eQMS [timeframe] Per 21 CFR 211.180 [VERIFY]
Calibration log Engineering Paper/eQMS [timeframe] [policy]
Training record QA/HR LMS/eQMS [timeframe] [policy]

If electronic: require validation, audit trails, access control, e-signatures per Part 11.

11. Training and Qualification

  • Initial training before first execution
  • Retraining on each revision
  • Qualification for roles with critical steps
  • Document training effectiveness

12. Change Control and Revision History

Version Effective Date Change Summary Rationale Approvers
1.0 [date] Initial release [reason] [names]

13. References

List all cited standards with version/date. Mark uncertain items [VERIFY].

14. Appendices

Include controlled templates: SOP execution checklist, batch record template, deviation report template, in-process control log, equipment cleaning log.

Pitfalls and Checks

  • Language — use imperative, unambiguous phrasing; never advisory ("should consider")
  • Citations — verify all regulatory citations are current; mark uncertain ones [VERIFY]
  • Role segregation — maintain separation between production and QA/QC functions
  • Retention — apply the strictest applicable retention requirement across jurisdictions
  • Jurisdiction — add annexes for non-U.S. markets (EU, WHO, PIC/S requirements)
  • Part 11 — confirm electronic record controls whenever eQMS or e-signatures are used

Comments

Loading…

Related Skills

United States flagUnited States · life-sciences

Quality Agreement for Contract Manufacturing

Drafts Quality Agreements for pharmaceutical contract manufacturing. Assigns quality roles between product owners and CMOs under FDA cGMP (21 CFR 210…

CaseMark
United States flagUnited States · life-sciences

Promotional Materials Review Policy

Drafts an internal Promotional Materials Review Policy for life sciences and pharmaceutical companies under FDA oversight. Covers promotional review …

CaseMark
United States flagUnited States · life-sciences

Pharmaceutical Regulation Compliance Summary

Generates structured pharmaceutical regulatory compliance summaries covering FDA approval pathways, patent/IP intersections (Orange Book, Hatch-Waxma…

CaseMark
United States flagUnited States · life-sciences

New Drug Application (NDA)

Drafts an eCTD-compliant New Drug Application (NDA) for FDA submission under 21 CFR Part 314. Compiles clinical trial data, CMC documentation, noncli…

CaseMark
United States flagUnited States · life-sciences

Investigator Agreement

Drafts Investigator Agreements for FDA-regulated clinical trials between sponsors and principal investigators. Covers 21 CFR Parts 50, 56, 312/812, I…

CaseMark